DR5 (Trail-R2) was highly expressed in the synovial tissue and fibroblasts from RA and specific activation of Trail-DR5 signaling was effective for ameliorating the arthritis phenotype of RA [21]. Here, TNFRSF10B is linked to arthritic joint disease.